Navigation Links
TPI Discusses Non-Cash Non-Operational Financial Impact from Warrants
Date:6/17/2011

cided to amend the Company's Form 10-Qs for the quarters ended September 30, 2010, December 31, 2010 and March 31, 2011 reporting periods including the comparative prior year period in these filings to reflect the non-cash, non-operational financial impact from the reclassification of the Warrants. The Company will also make corresponding revisions to its financial statements for the fiscal year ended June 30, 2010 in the Form 10-K for the fiscal year ended June 30, 2011.

About TPIHeadquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and active pharmaceutical ingredients (API). TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit:  http://www.tianyinpharma.com.

Safe Harbor StatementThe Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit: http://www.tianyinpharm
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
2. VHGI Discusses Recent Addition to the Regulation SHO Threshold Security Listing
3. Robotic Surgery Expert Dr. David B. Samadi, MD Discusses New Evidence That Proves The Low Complication Rates of Robotic Prostatectomy
4. With Over 3,000 Robotic Prostatectomy Surgeries to His Credit, Dr. David Samadi, MD Discusses SMART Surgery and How it Improves Sexual and Urinary Function
5. Prostate Cancer Treatment Expert Dr. David Samadi, MD Discusses Study Which Found That Low-Income Men Had High-Risk Prostate Cancer Tumors
6. Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone
7. Robotic Surgery Expert Dr. David Samadi, MD Discusses FDA Warnings on the Effect of GnRH Agonists
8. New York Robotic Surgery Expert Dr. David Samadi, MD Discusses New Findings that Hormone Therapy May Increase Risk of Developing Colorectal Cancer
9. Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study
10. Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment
11. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015  IRIDEX Corporation (NASDAQ: IRIX ... and full year 2014 financial results after the market closes ... the release, the Company will host a conference call with ... Thursday, March 5, 2015 to discuss the ... Interested parties may access the live conference call via telephone ...
(Date:2/26/2015)... DALLAS , February 26, 2015 ... EU Outlook 2015: First -In- Class Innovations and ... Business for Large Cap Pharmaceutical Companies research report ... According to this Global Pharma US ... divested as productivity measurements, divestment of non-core assets ...
(Date:2/26/2015)... 2015 The report, "Bottled ... Filler, Capper, Blow molder, Shrink wrapper), Technology (RO, ... Sparkling) & Region - Trends & Forecasts to ... bottled water processing market with analyses and projection ... value. It also identifies the driving and restraining ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4
... YORK, Jan. 13, 2011 Reportlinker.com announces that ... its catalogue: Merck & Co., ... IntroductionThis analysis examines the ... in the prescription pharmaceutical sector. The profile encompasses ...
... Codexis, Inc. (Nasdaq: CDXS) today announced the company will host ... at 4:30 p.m. Eastern Time to discuss its fourth quarter ... call and webcast will follow the release of fourth quarter ... call will be available approximately one hour after the call ...
Cached Medicine Technology:Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
(Date:2/26/2015)... When Cosmetic Town launched in 2012, its Board ... will soon be, the cornerstone of work that bolsters ... insight that will be accessible to the public, will ... maintained during its existence. Users have more data to ... visiting the Cosmetic Town Journal’s doctor’s page. There the ...
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 ... wound center management, recently expanded its executive team by ... care industry experience. At the same time two WCA ... company. Wound Care Advantage (WCA) was founded in 2002 ... companies still operating today. The WCA team believes that ...
(Date:2/26/2015)... Somerset, NJ (PRWEB) February 26, 2015 ... global provider of advanced delivery technologies and ... health products, has today announced several expanded ... network. The expansions have been implemented in ... clinical packaging, where the proportion of highly-potent ...
(Date:2/26/2015)... 26, 2015 The Reproductive Science Center ... newly renovated office in Lawrenceville, NJ. , ... of New Jersey’s physicians, and NJ Top Docs, have ... in the areas of infertility and reproductive medicine. This ... success rates and providing current, high quality medical treatments ...
(Date:2/26/2015)... Ann Arbor, Michigan (PRWEB) February 26, 2015 ... two different procedures that accomplish two different things—but they ... procedure. When blending a tummy tuck with liposuction, Michigan’s ... LipoTuck ,” which he's seen grow in popularity by ... practice. , Why are more patients seeking to combine ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town has now Recreated Itself by Adding New Features 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 2Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Dr. Pramit Malhotra Reports a Rise in Patients Combining Liposuction and Tummy Tuck in Michigan, Citing the “Power LipoTuck” 2Health News:Dr. Pramit Malhotra Reports a Rise in Patients Combining Liposuction and Tummy Tuck in Michigan, Citing the “Power LipoTuck” 3
... “black box warning” to three asthma drugs//, Foradil, ... the manufacturers that the drug should carry clearly ... ,Adavir and Serevent are manufactured by ... the drug Foradil which contains a different long-acting ...
... for all chocolate lovers, as against the general thought ... that dark chocolate can actually improve heart function. ... dark chocolate consumption on blood vessel function in 17 ... these subjects exhibited a 7 % decrease in aortic ...
... People suffering from irritable bowel syndrome may be having ... bowel syndrome is one of the most common gastrointestinal ... abdominal pain and changed bowel habits with no particular ... for the condition. ,Scientists from St. George's ...
... early breast cancer// patients increased the risk of ... study published in Journal of clinical oncology reports ... higher than standard cumulative doses of epirubicin and ... myeloid leukemia (AML) or Myelodysplastic syndrome (MDS). ...
... believe it but science is skeptical about it.// However there ... healing. ,Some scientists also now are starting to ... others, influence our health. ,The new age healing mantra ... approach to wellness”, which unites the science of medicine with ...
... from injuries. However at times due to age or ... Researchers have identified a molecule that when is deficient, ... from University of Illinois-Chicago had reported in their findings ... and this may be targeted to treatment in cases ...
Cached Medicine News:Health News:FDA gives “black box warning” against three asthma dru 2Health News:High-Dosage of Epirubicin and Cyclophosphamide may cause AML 2Health News:Link between Faith, Health and Healing 2Health News:Link between Faith, Health and Healing 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: